Search for: "Abbott v. Abbott" Results 1901 - 1920 of 2,325
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
1 Apr 2011, 5:49 pm by INFORRM
MGN Ltd v United Kingdom – ECHR condemns excessive success fees, Eleanor Steyn & Gillie Abbotts (Michael Simkins LLP) Entertainment Law Review Ent. [read post]
29 Dec 2010, 2:57 am by Marie Louise
(Kluwer Patent Blog) US: BIO sends letter to DOJ on ‘clear and convincing evidence’ question raised in Microsoft v. i4i (Patent Docs) US: CAFC: Broad scope of statutory subject matter: Prometheus Laboratories, Inc. v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
2 Dec 2015, 6:21 am by Guest Blogger
Abbott, No. 14-940 (U.S. 2015), in which the Petitioners, a pair of Texas voters, seek to dramatically change the constitutional requirements for redistricting state legislatures. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO:… [read post]
18 Apr 2008, 2:00 am
Protecting computer programs under the Copyright Act: Dais Studios v Bullet Creative: (IP Down Under), Assessing copyright risk in new classroom technologies: (IP Down Under), Cadbury loses battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law Blog), (IP Down Under), (IPKat), (IPwar’s), Employee or independent contractor? [read post]
14 Sep 2015, 7:41 am by John McFarland
Another recent example is BCCA Appeal Group, Inc. v. [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]